Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It appears formulab is on the cusp of much larger trials once the expanded (30)..... which are looking likely to be successful on completion. It also appears this treatment works for many inflammatory conditions
With the patented drug delivery we may get a surprise, but we need to get past the next fundraising first!!
As a LTH . I have watched the share price drift lower on no news and low volumes
recently we have had some very promising news on developments and much higher volumes as the share price rises
I take this to be a good sign as (hopefully) institutional investors come on board
In any case I see this company being bankrolled by our founder and with his many successes in BIO, i expect a buy out of the company within a couple of years, by which time the price will be multiples higher
Long term hold
GLA
Possibly so, I'm also unsure what to make of it. The SP reaction continues to be positive, up to 86c today. Still a long way off the levels most have bought at, and still below the $1 threshold for NASDAQ holdings.............but it seems to have momentum and perhaps something will come of it
Not really sure how to rate this news. On a scale of 10 I would say 6/10? Its good but not very good.
I can only see big rewards for us holders if TLSA partners with a major pharma to develop foralumab.
Tweet on X;
‘ Today We Have Announced 70% of Patients in the Non-Active Secondary Progressive Multiple Sclerosis Expanded Access Program Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Treatment with Nasal Foralumab. All Patients Have Either Stabilized or Improved and No Patients Declined in Key Clinical Measures. $TLSA
In the below table we show either an improvement or stabilization in these key clinical measures.
— Denotes stabilization ↓ Denotes improvement
#MultipleSclerosis #MS #SPMS #PIRA #SmoulderingMS ir.tizianalifesciences.com/news-releases/…
Released today on most big news sites
SP flying today, up to 72c. I know they were doing a presentation, so i presume this is on the back of that. Looks promising, unlike Accustem. I don't even know if i'd be able to sell the paltry amount of Accustem shares i have, i imagine they're very illiquid
Up to 58¢ today, was 42¢ recently and over 80¢ a few months back. Accustem aside, wtf is going on here, anyone?
What’s going on FFS
Still hold some free Accustem shares from the Tils meger back in 2020. Not been keeping up with whats happening. Do we see Accumstem running out of cash and winding up or there any chance the SP can move in the right direction?
Thats the MCAP then
“ As of December 31, 2023, our cash balance is $21,481 which is not adequate for our current planned level of operations, through at least April 2024.”
Taken from the recent 10K filed on 22nd March 2024 covering up to Dec 2023.
?
@ current bid of 0.365 dollars you’re buying around 3 accustem shares for £1 sterling.
To have 3 accustem shares at the current consolidated level you would have had to have I believe 60 Tiziana shares at EX date in October 2020 which were around £1.80 per share. So, if I’m right,
£1 of accustem shares now buys you around £108 worth of accustem shares in October 2020 (or tils shares you had to hold for the entitlement).
MCAP is currently around $4m USD so circa £3.2m sterling.
Is this a wild bargain or an absolute waste.
How are they still operating when they only had like $70k cash in September or something and their burn rate was say $60k a month?
Does anyone want to update shareholders as to what is happen? Is accustem still trading?
What the hell is going on? They said they would be presenting data in January wasn’t it? No updates, share price destroyed, no cash and no comments
Ex date was 4 years ago this year.
Any updates? Paul the plumber is there any update with accustem? Aren’t you doing PR there now?
No updates since what last June or something ?
So they moved from AIM to the Nasdaq and it just keeps tanking despite all the news updates.
7th June 2023 was the interview with proactive investors, over 8 months now and no update on commercialisation or the university hospital collab outcome.
Sick of this.
Someone on stocktwits is feeling the same as me RE accustem. How are they still functioning with no cash
Where’s the PR GUY? It’s 10% of the way through 2024 now and no accustem updates
'At last after 28 months'
Bl**dy traders ruining this share!
At last after 28 months. I was just preparing to provide the Ombudsman with documents from my complaint !!
My Barclays account is quoting TILS in USA dollars and showing them as sellable this morning!
Is the plumber/PR guy still ramping on these boards ?
Is there an update on accustem ?
Is Tiziana staying on Nasdaq ?
What happened to the accustem university hospital data sets?
How are accustem funding operations.
WHAT IS HAPPENING?
1133 days since the accustem ex date,
4 years this year and no uplisting. I know biotech has been in a bear market but why not update regular long term holders ?
It just stinks.
No updates on accustem.
What a load of old cobblers. Into our 4th year now